162 related articles for article (PubMed ID: 16285330)
1. Changes in prevalence of and prescribing for ischaemic heart disease in Ireland 1990-2002.
Bennett K; Johnson H; Dack P; Shelley E; Feely J
Ir J Med Sci; 2005; 174(3):4-8. PubMed ID: 16285330
[TBL] [Abstract][Full Text] [Related]
2. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.
Sharma KK; Gupta R; Agrawal A; Roy S; Kasliwal A; Bana A; Tongia RK; Deedwania PC
Vasc Health Risk Manag; 2009; 5():1007-14. PubMed ID: 19997570
[TBL] [Abstract][Full Text] [Related]
3. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States.
Stafford RS; Monti V; Furberg CD; Ma J
Hypertension; 2006 Aug; 48(2):213-8. PubMed ID: 16785334
[TBL] [Abstract][Full Text] [Related]
4. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barón AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K
Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896
[TBL] [Abstract][Full Text] [Related]
5. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis.
Hippisley-Cox J; Coupland C
BMJ; 2005 May; 330(7499):1059-63. PubMed ID: 15879390
[TBL] [Abstract][Full Text] [Related]
6. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
7. Under-prescribing of cardiovascular therapies for diabetes in primary care.
Bennett KE; Williams D; Feely J
Eur J Clin Pharmacol; 2003 Apr; 58(12):835-41. PubMed ID: 12698311
[TBL] [Abstract][Full Text] [Related]
8. ACE up the sleeve - are vascular patients medically optimized?
Coveney AP; O'Brien GC; Fulton GJ
Vasc Health Risk Manag; 2011 Jan; 7():15-21. PubMed ID: 21339909
[TBL] [Abstract][Full Text] [Related]
9. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
Yahia DH; Pereg D; Lishner M; Elis A
Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639
[TBL] [Abstract][Full Text] [Related]
10. Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care.
Williams D; Bennett K; Feely J
Br J Clin Pharmacol; 2003 Jun; 55(6):604-8. PubMed ID: 12814456
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of cardioprotective pharmacological agent use in stable coronary heart disease.
Sharma KK; Mathur M; Gupta R; Guptha S; Roy S; Khedar RS; Gupta N; Gupta R
Indian Heart J; 2013; 65(3):250-5. PubMed ID: 23809376
[TBL] [Abstract][Full Text] [Related]
12. Prescription of statins: cost implications of evidence-based treatment applied to a health authority population.
Bradshaw N; Walker R
J Clin Pharm Ther; 1997; 22(5-6):379-89. PubMed ID: 19160723
[TBL] [Abstract][Full Text] [Related]
13. Age, sex and practice variations in the use of statins in general practice in England and Wales.
Majeed A; Moser K; Maxwell R
J Public Health Med; 2000 Sep; 22(3):275-9. PubMed ID: 11077897
[TBL] [Abstract][Full Text] [Related]
14. Inequalities in prescribing of secondary preventative therapies for ischaemic heart disease in Ireland.
Bennett KE; Williams D; Feely J
Ir Med J; 2002 Jun; 95(6):169-72. PubMed ID: 12171263
[TBL] [Abstract][Full Text] [Related]
15. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction.
Berger AK; Duval S; Krumholz HM
J Am Coll Cardiol; 2003 Jul; 42(2):201-8. PubMed ID: 12875751
[TBL] [Abstract][Full Text] [Related]
16. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.
Kizer JR; Cannon CP; McCabe CH; Mueller HS; Schweiger MJ; Davis VG; Perritt R; Antman EM
Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home.
Joseph J; Koka M; Aronow WS
J Am Med Dir Assoc; 2008 Feb; 9(2):124-7. PubMed ID: 18261706
[TBL] [Abstract][Full Text] [Related]
18. The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.
Hawkins NM; Scholes S; Bajekal M; Love H; O'Flaherty M; Raine R; Capewell S
Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):208-16. PubMed ID: 23481523
[TBL] [Abstract][Full Text] [Related]
19. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
20. Cardiac medical therapy among patients undergoing abdominal aortic aneurysm repair.
Kurzencwyg D; Filion KB; Pilote L; Nault P; Platt RW; Rahme E; Steinmetz O; Eisenberg MJ
Ann Vasc Surg; 2006 Sep; 20(5):569-76. PubMed ID: 16794911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
